EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted near-infrared imaging utilizing a cathepsin-activated fluorophore for the intraoperative detection of canine insulinoma

Maureen A Griffin iD, Enrico Radaelli, Charles-Antoine Assenmacher iD, Sunil Singhal, Robert E Roses, Brian K Flesner, Darko Stefanovski iD, Nimar Gill, Jennifer L Huck, Heather Scavello, Jillian Verrelle, Kristen Farrell und 1 weitere

PLOS One · 2026

DOI: 10.1371/journal.pone.0343299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Maureen A Griffin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences and Advanced Medicine, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United S…. Hauptthemen laut MEDLINE: Insulinoma, Fluorescent Dyes, Pancreatic Neoplasms, Cathepsin B. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Companion Animal Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aim of this study was to evaluate the use of cathepsin-activated intraoperative near-infrared (NIR) imaging to detect insulinomas in dogs, a spontaneous large animal model for human disease. Materials and methods A prospective, pilot clinical trial was performed on dogs with naturally occurring insulinomas undergoing exploratory laparotomy. Each dog underwent routine preoperative diagnostic assessment, and a cathepsin-activated fluorophore (VGT-309) was administered intravenously 1–2 days preoperatively. All intraoperative findings with visible light and NIR imaging were recorded and mean NIR fluorescence intensity of tumors and grossly normal pancreas were quantified. Excision of any identified primary tumor and suspected metastatic lesions was performed. All excised tissues underwent histologic evaluation and immunohistochemistry (IHC) for cathepsin B expression. Descriptive statistics were calculated, and differential fluorescence intensity and cathepsin B expression between the pancreatic mass and adjacent grossly normal pancreatic tissue were assessed for statistical significance via paired t tests with p < 0.05 used for significance.

Results

Six dogs were enrolled. No adverse events occurred secondary to administration of the imaging agent. In situ, insulinomas had significantly greater mean fluorescence intensities than the surrounding pancreas, and the median tumor to background ratio was 1.906 (range 1.286–2.556). One dog had an occult pancreatic mass that was identified intraoperatively with NIR guidance. Background fluorescence of liver and lymph nodes was observed in all cases, and one dog was diagnosed with nodal and hepatic metastasis. Histologic tumor margins correlated with margins of NIR fluorescence. Cathepsin B expression was determined to be significantly greater in the pancreatic tumor compared to adjacent non-neoplastic pancreas via IHC, and there was no overlap in the range of median IHC-positive proportion values for these tissues. However, there was overlap in the range of IHC-positive proportion values for neoplastic pancreatic samples and lymph node and liver tissues. Clinical significance The findings of this pilot study support further investigation of cathepsin-activated NIR imaging to enhance intraoperative canine insulinoma localization and margin evaluation. Future studies are needed to further characterize and optimize the utility of targeted NIR imaging, particularly to identify metastatic lesions, for canine insulinoma, which may serve as an effective translational model for humans with pancreatic neuroendocrine tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinomaFluorescent DyesPancreatic NeoplasmsCathepsin BDog DiseasesCathepsinsAnimalsDogsSpectroscopy, Near-InfraredFemalePilot ProjectsMaleIntraoperative Period

Substanzen

Fluorescent DyesCathepsin BCathepsins

Autor:innen und Institutionen

  • Department of Clinical Sciences and Advanced Medicine, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of America.
  • Department of Pathobiology, Penn Vet Comparative Pathology Core, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of America.
  • Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America.
  • Cancer Biology and Experimental Therapeutics Laboratory, Colorado State University College of Veterinary Medicine and Biomedical Sciences, Fort Collins, Colorado, United States of America.

ORCID-Profile: Maureen A Griffin, Charles-Antoine Assenmacher, Darko Stefanovski

Förderung

  • Companion Animal Research Fund

Zitieren

APA

Griffin, M. A., Radaelli, E., Assenmacher, C. A., Singhal, S., Roses, R. E., Flesner, B. K., Stefanovski, D., Gill, N., Huck, J. L., Scavello, H., Verrelle, J., Farrell, K., & Holt, D. E. (2026). Targeted near-infrared imaging utilizing a cathepsin-activated fluorophore for the intraoperative detection of canine insulinoma. PLOS One. https://doi.org/10.1371/journal.pone.0343299

Vancouver

Griffin MA, Radaelli E, Assenmacher CA, Singhal S, Roses RE, Flesner BK, et al. Targeted near-infrared imaging utilizing a cathepsin-activated fluorophore for the intraoperative detection of canine insulinoma. PLOS One. 2026. doi:10.1371/journal.pone.0343299

BibTeX
@article{Griffin2026,
  author = {Griffin, Maureen A and Radaelli, Enrico and Assenmacher, Charles-Antoine and Singhal, Sunil and Roses, Robert E and Flesner, Brian K and Stefanovski, Darko and Gill, Nimar and Huck, Jennifer L and Scavello, Heather and Verrelle, Jillian and Farrell, Kristen and Holt, David E},
  title = {Targeted near-infrared imaging utilizing a cathepsin-activated fluorophore for the intraoperative detection of canine insulinoma},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0343299}
}
Kostenlos starten →